Literature DB >> 22021073

Health care expenditures among children with and those without spina bifida enrolled in Medicaid in North Carolina.

Cynthia H Cassell1, Scott D Grosse, Phoebe G Thorpe, Eleanor E Howell, Robert E Meyer.   

Abstract

BACKGROUND: National data on health care use among children with special needs are limited and do not address children with spina bifida (SB). One recent study examined health care costs during 2003 among privately insured individuals with SB. Our objective was to compare health care use and expenditures among publicly insured children with SB to children without a major birth defect and among children with SB with and without hydrocephalus.
METHODS: Data from the North Carolina Birth Defects Monitoring Program and Medicaid were linked to identify continuously enrolled children with SB (case children) and children without a major birth defect (control children) born from 1995 to 2002. Medicaid expenditures per child for medical, inpatient, outpatient, dental, well-child care, developmental/behavioral services, and home health for those aged 0 to 4 years old were calculated for case and control children and for case children with and without hydrocephalus.
RESULTS: Of 373 case children who survived infancy, 205 (55%) were enrolled in Medicaid. Expenditures were assessed for 144 case and 5674 control children aged 0 to 4 years old continuously enrolled in Medicaid. During infancy, mean expenditure was $33,135 per child with SB and $3900 per unaffected child. The biggest relative expenditures were for developmental/behavioral services (82 times higher for case than control child [$1401 vs. $17]) and home health services (20 times higher [$821 vs. $41]). Average expenditure for an infant with SB and hydrocephalus was 2.6 times higher than an infant with SB without hydrocephalus ($40,502 vs. $15,699).
CONCLUSIONS: Expenditure comparisons by SB subtype are important for targeting health care resources.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22021073     DOI: 10.1002/bdra.22864

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  7 in total

Review 1.  Prevention of myelomeningocele: African perspectives.

Authors:  Taopheeq Bamidele Rabiu; Amos Olufemi Adeleye
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

2.  Factors Associated with Travel Time and Distance to Access Hospital Care Among Infants with Spina Bifida.

Authors:  Elizabeth Radcliff; Eric Delmelle; Russell S Kirby; Sarah B Laditka; Jane Correia; Cynthia H Cassell
Journal:  Matern Child Health J       Date:  2016-01

Review 3.  New directions in fetal surgery for myelomeningocele.

Authors:  Sandra K Kabagambe; Y Julia Chen; Melissa A Vanover; Payam Saadai; Diana L Farmer
Journal:  Childs Nerv Syst       Date:  2017-05-11       Impact factor: 1.475

4.  Factors associated with the timeliness of postnatal surgical repair of spina bifida.

Authors:  Elizabeth Radcliff; Cynthia H Cassell; Sarah B Laditka; Judy K Thibadeau; Jane Correia; Scott D Grosse; Russell S Kirby
Journal:  Childs Nerv Syst       Date:  2016-05-14       Impact factor: 1.475

5.  Medicaid healthcare expenditures for infants with birth defects potentially related to Zika virus infection in North Carolina, 2011-2016.

Authors:  Kristin Bergman; Nina E Forestieri; Vito L Di Bona; Scott D Grosse; Cynthia A Moore
Journal:  Birth Defects Res       Date:  2022-01-04       Impact factor: 2.661

6.  Emergent care patterns in patients with spina bifida: a case-control study.

Authors:  Hsin-Hsiao S Wang; John S Wiener; Sherry S Ross; Jonathan C Routh
Journal:  J Urol       Date:  2014-07-09       Impact factor: 7.450

7.  Hospital use, associated costs, and payer status for infants born with spina bifida.

Authors:  Elizabeth Radcliff; Cynthia H Cassell; Jean Paul Tanner; Russell S Kirby; Sharon Watkins; Jane Correia; Cora Peterson; Scott D Grosse
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.